Drawing for FINDING CANCER EARLY EPIGENOMICS

USPTO serial 77941080

FINDING CANCER EARLY EPIGENOMICS

Reviewed by CopyMark Law Group

Reg. 3932970Status 710
Filing date
Status date
Registration date
Mar 15, 2011
Examiner
HOLTZ, ALLISON
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with FINDING CANCER EARLY EPIGENOMICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001chemicals used in industry and science; diagnostic reagents for scientific research use, namely, for forensic examinations and test kits used in science, in particular for verifying, diagnosing and monitoring and predicting the progress and post treatment of illnesses, such as inflammatory, infectious, central nervous system, cardiovascular, neurological, endocrine, autoimmune and genetic diseases and cancer; chemical test kits for scientific purposes, in particular for diagnoses, consisting of reagents, processing chemicals and solid matrix materials for applying reagentsSECTION 8 - CANCELLED
005pharmaceutical products for the prevention of cancer and for the treatment of cancer; reagents for medical use, for verifying, diagnosing and monitoring and predicting the progress and post treatment of inflammatory, infectious, central nervous system, cardiovascular, neurological, endocrine, autoimmune and genetic diseases and cancer; medical test kits, consisting of chemical preparations for medical purposes, in particular for the detection of pathogens in the environment; reagents and chemical reagents as part of test kits for medical purposesSECTION 8 - CANCELLED
009laboratory apparatus, in particular apparatus for screening samples, for detecting the presence of substances in samples and for identifying sample types; microscope slides, in particular as part of test kitsSECTION 8 - CANCELLED
042research and development services for third parties in the field of diagnostic chemicals, reagents, markers, forensic methods, compositions and devices, measuring apparatuses for use in product research and development, product research and development, in methods for preparation and purification, in methods for testing the environment and in industrial quality methods; chemical separation analysis and diagnoses for scientific purposes for third parties; computer programming for data processing; customized searching, namely, providing specific information as requested by customers via the internet; recording data for others on optical, digital and magnetic media for electronic storageSECTION 8 - CANCELLED
044medical services, in particular forensic and medical gene analyses for third parties and chemical diagnoses for medical purposes for third parties; health care for third partiesSECTION 8 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 20, 2017C8..CANCELLED SEC. 8 (6-YR)
Mar 15, 2011R.SRREGISTERED-SUPPLEMENTAL REGISTERYour mark is registered on the Supplemental Register, which is available for marks that are not yet distinctive enough for the Principal Register but can still identify a source. Protection is more limited than Principal Register registration but can later support a Principal Register application.
Feb 4, 2011PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Jan 29, 2011CNTAAPPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Jan 5, 2011TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Jan 5, 2011CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 5, 2011ALIEASSIGNED TO LIE
Dec 7, 2010TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 7, 2010CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 5, 2010CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 26, 2010DOCKASSIGNED TO EXAMINER
Feb 27, 2010MDSCNOTICE OF DESIGN SEARCH CODE MAILED
Feb 26, 2010NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 25, 2010NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance